Medication info
Remed Tablet 2mg (Glimepiride)

Remed Tablet 2mg (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Eden Pharma Co., Ltd.
Appearance
Green rectangular tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201403961 · Approved 2014.08.25 · Insurance code 628900070

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. This medicine should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, but some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering drug to this medicine There is no exact dose equivalence between this medicine and other oral blood glucose-lowering drugs. When switching from another oral blood glucose-lowering drug to this medicine, it is recommended to follow the procedure described under Initial dose. That is, treatment may be initiated at 1 mg once daily, with dose adjustment at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered drug should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. This medicine is administered at a dose of 8 mg once daily with the first meal, while insulin is initiated at a low dose and increased approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this medicine is administered in combination with metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Eden Pharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone, and if blood sugar control is challenging with monotherapy, it may be used in combination with other oral hypoglycemics or insulin. Additionally, if blood sugar control is insufficient with sulfonylureas or metformin monotherapy, combination therapy with metformin can be utilized. This effectively helps improve the patient's blood sugar levels.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. This medicine should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, but some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering drug to this medicine There is no exact dose equivalence between this medicine and other oral blood glucose-lowering drugs. When switching from another oral blood glucose-lowering drug to this medicine, it is recommended to follow the procedure described under Initial dose. That is, treatment may be initiated at 1 mg once daily, with dose adjustment at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered drug should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. This medicine is administered at a dose of 8 mg once daily with the first meal, while insulin is initiated at a low dose and increased approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this medicine is administered in combination with metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or diabetic ketoacidosis, or those in a state of coma. Patients allergic to this medication, its components, or sulfonylureas should also not take it. It is not recommended for use in patients with severely impaired liver or kidney function as safety has not been established; in such cases, switching to insulin therapy is advised. Women who are pregnant or likely to become pregnant, as well as nursing mothers, should not take this medication. Patients with severe infections, or those undergoing surgery or experiencing severe trauma may require insulin therapy. Care should be taken when gastrointestinal issues such as diarrhea or vomiting are present, as food absorption may be compromised, increasing the risk of hypoglycemia. During the first week of taking the medication, there is a heightened risk of hypoglycemia, necessitating close monitoring of blood sugar levels. Special caution is required for the elderly, those with poor nutritional status, irregular eaters, or individuals whose exercise and food intake do not match. Those consuming alcohol or with impaired kidney or liver function may also respond sensitively to hypoglycemia, so careful intake is necessary. Furthermore, overdosage or abnormalities in thyroid, pituitary, or adrenal function can increase the risk of hypoglycemia. When taking this medication alongside others, potential interactions may occur, thus it is imperative to inform your doctor or pharmacist for proper management. This medication has a blood sugar-lowering effect, which could lead to symptoms of hypoglycemia. Symptoms include headache, severe hunger, nausea, fatigue, drowsiness, anxiety, confusion, visual disturbances, dizziness, weakness, and in severe cases, loss of consciousness or coma. Severe hypoglycemia can present symptoms similar to a stroke, thus immediate treatment is required. Additionally, blurred vision may occur initially, along with gastrointestinal symptoms such as nausea, vomiting, abdominal pain, or diarrhea. Serious side effects such as liver dysfunction or decreased blood cell counts may also occur rarely, so any abnormal symptoms should be reported to a healthcare professional immediately. When taking this medication, it is essential to take it regularly in conjunction with dietary and exercise therapy for optimal blood sugar control. In case of hypoglycemia, it is important to consume sugar or sugary beverages quickly, and it is advisable to always carry sugar. Education on hypoglycemic symptoms and their management should be thoroughly provided to patients and their families. Regular blood sugar and urine tests should be performed during treatment to monitor the drug's efficacy and side effects, and dosage adjustments should be discussed with a doctor if conditions change. Furthermore, caution should be exercised during driving or operating machinery to avoid accidents due to hypoglycemia. As this medication is metabolized in the liver, its interaction with specific drugs may affect blood sugar control. Notably, some antibiotics, antifungals, antihypertensives, and anticoagulants may interact, hence it is crucial to inform healthcare providers about other medications being taken. Alcohol intake can unpredictably affect blood sugar control, necessitating caution, and adjusting the timing of medication intake is also important. Pregnant or breastfeeding women should avoid this medication as it may harm the fetus or newborn. In cases of planned pregnancy, consulting with a doctor to choose alternative methods like insulin therapy is advisable. The safety of this medication has not been adequately established in children and adolescents under 18 years, and therefore, it should not be used as a principle. For the elderly, careful attention is needed due to potentially diminished kidney function, including dosage adjustments. In the event of overdose, severe hypoglycemia may occur, necessitating immediate emergency treatment. Induction of vomiting, gastric lavage, or glucose injection may be required. This medication should be stored in a safe place out of the reach of children, in its original container to prevent misuse or degradation of quality.

Side effects

  • Hypoglycemia
  • headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep
  • sleep disorders
  • anxiety
  • aggression
Show 68 more
  • decreased concentration
  • decreased agility or motivation
  • depression
  • confusion
  • speech abnormalities
  • aphasia
  • visual impairment
  • tremors
  • incomplete paralysis
  • sensory abnormalities
  • dizziness
  • weakness
  • loss of self-control
  • transient mental confusion
  • brain convulsions
  • drowsiness
  • loss of consciousness
  • coma
  • shallow breathing
  • bradycardia
  • sweating
  • cold clammy skin
  • tachycardia
  • hypertension
  • palpitations
  • angina pectoris
  • deep vein thrombosis
  • blurred vision
  • feeling of fullness in the upper abdomen
  • pressure
  • abdominal pain
  • diarrhea
  • increased liver enzymes
  • liver dysfunction
  • biliary secretion disorders
  • jaundice
  • hepatitis
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythrocytopenia
  • neutropenia
  • agranulocytosis
  • pancytopenia
  • itching
  • urticaria
  • rash
  • dyspnea
  • hypotension
  • shock
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • allergic vasculitis
  • photosensitivity reactions of the skin
  • decreased serum sodium concentration
  • taste disorders
  • hair loss
  • weight gain
  • dizziness
  • liver dysfunction
  • abdominal pain
  • arthralgia
  • dyspepsia
  • facial swelling
  • erectile dysfunction
  • flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is best stored at room temperature between 1°C and 30°C. This will help maintain its efficacy for a longer duration.

Appearance and packaging

Appearance

Green rectangular tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.